Ascendis Pharma A (ASND) Net Margin (QoQ) (2014 - 2026)
Ascendis Pharma A (ASND) Net Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,462.00 |
| Dec 31, 2025 | 2,111.00 |
| Sep 30, 2025 | -382.00 |
| Jun 30, 2025 | 6,834.00 |
| Mar 31, 2025 | -8,140.00 |
| Dec 31, 2024 | 15,911.00 |
| Sep 30, 2024 | -47,538.00 |
| Jun 30, 2024 | 16,720.00 |
| Mar 31, 2024 | 16,584.00 |
| Dec 31, 2023 | 30,853.00 |
| Sep 30, 2023 | -59,609.00 |
| Jun 30, 2023 | 59,092.00 |
| Mar 31, 2023 | 57,341.00 |
| Dec 31, 2022 | 21,348.00 |
| Sep 30, 2022 | 21,297.00 |
| Jun 30, 2022 | 50,559.00 |
| Mar 31, 2022 | -171,485.00 |
| Dec 31, 2021 | -734,219.00 |
| Sep 30, 2021 | -592,909.00 |
| Jun 30, 2021 | 2.16 Mn |